{"title":"Association between allergic diseases and mental health conditions: an umbrella review.","authors":"Xianpeng Xu, Sha Li, Yingjie Chen, Xinxing Deng, Jiongke Li, Dajing Xiong, Hui Xie","doi":"10.1016/j.jaci.2024.10.030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The mental health conditions of allergic diseases has been investigated, but the consistency and magnitude of their effects are unclear. The aim of this umbrella review is to systematically evaluate the published evidence on allergic diseases and mental health conditions to establish a new hierarchy of evidence and identify gaps in this area of research.</p><p><strong>Methods: </strong>We systematically searched PubMed, Embase, Web of Science and the Cochrane Database of Systematic Reviews from database inception to April 30, 2024. We included systematic reviews that conducted meta-analyses that examined the association of allergic diseases and mental health conditions. We calculated summary effect estimates (odds ratio [OR]), 95% confidence intervals, I<sup>2</sup>statistic, 95% prediction interval, small study effects, and excess significance biases. We used AMSTAR 2 to appraise the methodological quality of the included studies.</p><p><strong>Results: </strong>We identified 21 eligible articles which yielded 37 associations (38,4405,029 total population) of allergic diseases and mental health conditions. The credibility of evidence was convincing (class I) for asthma and risk of attention deficit/hyperactivity disorder (ADHD) (OR 1.34, 1.24-1.44); and highly suggestive (class II) for allergic rhinitis and risk of tic disorders (OR 2.61, 1.90-3.57), allergic rhinitis and risk of sleep disorders (OR 2.17, 1.87-2.53), food allergy and risk of autism spectrum disorder (ASD) (OR 2.79, 2.08-3.75), atopic dermatitis and risk of depression (OR 1.60, 1.43-1.79), atopic dermatitis and risk of anxiety (OR 1.62 1.42-1.85), atopic dermatitis and risk of ADHD (OR 1.28, 1.18-1.40), atopic dermatitis and risk of suicidal ideation (OR 1.44, 1.25-1.65), asthma and risk of depression (OR 1.64, 1.50-1.78), asthma and risk of anxiety (OR 1.95, 1.68-2.26), asthma and risk of tic disorders (OR 1.90, 1.57-2.30), asthma and risk of suicidal ideation (OR 1.52, 1.37-1.70), and asthma and risk of suicide attempts (OR 1.60, 1.33-1.92).</p><p><strong>Conclusions: </strong>Allergic diseases are associated with increased risk of a range of mental health conditions, with the most convincing evidence that asthma. However, these associations do not imply causality, and there is large heterogeneity in these associations, which requires high-quality preliminary studies to identify causality and strength of evidence.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2024.10.030","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The mental health conditions of allergic diseases has been investigated, but the consistency and magnitude of their effects are unclear. The aim of this umbrella review is to systematically evaluate the published evidence on allergic diseases and mental health conditions to establish a new hierarchy of evidence and identify gaps in this area of research.
Methods: We systematically searched PubMed, Embase, Web of Science and the Cochrane Database of Systematic Reviews from database inception to April 30, 2024. We included systematic reviews that conducted meta-analyses that examined the association of allergic diseases and mental health conditions. We calculated summary effect estimates (odds ratio [OR]), 95% confidence intervals, I2statistic, 95% prediction interval, small study effects, and excess significance biases. We used AMSTAR 2 to appraise the methodological quality of the included studies.
Results: We identified 21 eligible articles which yielded 37 associations (38,4405,029 total population) of allergic diseases and mental health conditions. The credibility of evidence was convincing (class I) for asthma and risk of attention deficit/hyperactivity disorder (ADHD) (OR 1.34, 1.24-1.44); and highly suggestive (class II) for allergic rhinitis and risk of tic disorders (OR 2.61, 1.90-3.57), allergic rhinitis and risk of sleep disorders (OR 2.17, 1.87-2.53), food allergy and risk of autism spectrum disorder (ASD) (OR 2.79, 2.08-3.75), atopic dermatitis and risk of depression (OR 1.60, 1.43-1.79), atopic dermatitis and risk of anxiety (OR 1.62 1.42-1.85), atopic dermatitis and risk of ADHD (OR 1.28, 1.18-1.40), atopic dermatitis and risk of suicidal ideation (OR 1.44, 1.25-1.65), asthma and risk of depression (OR 1.64, 1.50-1.78), asthma and risk of anxiety (OR 1.95, 1.68-2.26), asthma and risk of tic disorders (OR 1.90, 1.57-2.30), asthma and risk of suicidal ideation (OR 1.52, 1.37-1.70), and asthma and risk of suicide attempts (OR 1.60, 1.33-1.92).
Conclusions: Allergic diseases are associated with increased risk of a range of mental health conditions, with the most convincing evidence that asthma. However, these associations do not imply causality, and there is large heterogeneity in these associations, which requires high-quality preliminary studies to identify causality and strength of evidence.
期刊介绍:
The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.